Triple
T9806872
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Chugai Pharmaceutical |
E238175
|
entity |
| Predicate | hasProduct |
P3585
|
FINISHED |
| Object |
Alecensa
Alecensa is a targeted cancer therapy (alectinib) primarily used to treat ALK-positive non-small cell lung cancer.
|
E821687
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69ca84defac48190abc1148804f184c1 |
elicitation | completed |
| NER | batch_69cdab7cb9588190953a063cb7b9e29e |
ner | completed |
| NED1 | batch_69d1c45a84d08190a7b5769d4a489b35 |
ned_source_triple | completed |
| NED2 | batch_69d1c5c0e6e88190bbf6eb379e6d1aa3 |
ned_description | completed |
| NEDg | batch_69d1c57aa5e081909262cb942fdc02c5 |
nedg | completed |
Created at: March 30, 2026, 8:29 p.m.